Actively Recruiting
Observational Study to Describe Clinical Characteristics and Biomarkers in Chinese Asthma Patients and Identify Phenotypes Linked to Different Outcomes
Led by AstraZeneca · Updated on 2026-08-18
355
Participants Needed
21
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a translational observational study to describe clinical characteristics, treatment patterns, and biomarkers in asthma patients within the Chinese population. The study aims to identify phenotypes and endotypes linked to different outcomes, which may help develop personalized treatment strategies in the future. The study includes healthy individuals as well as patients with mild to severe asthma, including those experiencing asthma exacerbations. Participants are grouped into cohorts approximately 80 healthy individuals, 40 mild asthmatics using low-dose inhaled corticosteroids ICS-formoterol or low-dose ICS with as-needed short-acting beta-2 agonists SABA, 160 moderate to severe asthmatics on low or medium dose ICS-long acting beta-2 agonists LABA, or high-dose ICS alone or combined with LABA, and 75 asthmatics with protocol-defined exacerbations. The study involves detailed collection of clinical data, treatment information, and biomarker measurements. During the study, participants undergo assessments including lung function tests such as FEV1, Forced Vital Capacity FVC, and Maximal Mid Expiratory Flow MMEF, imaging by computed tomography CT scan, and evaluation of airway remodeling and gas trapping at baseline. Researchers will also summarize demographic, clinical, and biomarker data and analyze associations between biomarkers and clinical outcomes over time. The study will continue through 2026, with participants monitored for treatment patterns and biomarker changes.
CONDITIONS
Brief Title
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
Research Team
A
AstraZeneca Clinical Study Information Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here